150 related articles for article (PubMed ID: 33285745)
1. Modified Maimendong decoction in the treatment of patients with idiopathic pulmonary fibrosis: Study protocol for a randomized controlled trial.
Gan W; Huang Q; Xiao G; Luo Y; Wang J; Zhang C; Liang Y; Huang N; Liao T
Medicine (Baltimore); 2020 Dec; 99(49):e23460. PubMed ID: 33285745
[TBL] [Abstract][Full Text] [Related]
2. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of an exploratory trial.
Yu XQ; Yang SG; Xie Y; Li JS
J Integr Med; 2020 Mar; 18(2):163-168. PubMed ID: 31928920
[TBL] [Abstract][Full Text] [Related]
3. Effects of Qizhukangxian granules on idiopathic pulmonary fibrosis: a randomized, double blind, placebo-controlled and multicenter clinical pilot trial.
Guo S; Song Y; Feng J; Liu S; Li Y; Liu M; Wei L; Zhang X; Xie H; Sun Z
J Tradit Chin Med; 2020 Aug; 40(4):674-682. PubMed ID: 32744035
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Kangxian Huanji Granule as adjunctive treatment in acute exacerbation of idiopathic pulmonary fibrosis: An exploratory randomized controlled trial.
Li JS; Zhang HL; Guo W; Wang L; Zhang D; Zhao LM; Zhou M
J Integr Med; 2023 Nov; 21(6):543-549. PubMed ID: 37993378
[TBL] [Abstract][Full Text] [Related]
5. Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Raghu G; van den Blink B; Hamblin MJ; Brown AW; Golden JA; Ho LA; Wijsenbeek MS; Vasakova M; Pesci A; Antin-Ozerkis DE; Meyer KC; Kreuter M; Santin-Janin H; Mulder GJ; Bartholmai B; Gupta R; Richeldi L
JAMA; 2018 Jun; 319(22):2299-2307. PubMed ID: 29800034
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial study protocol of modified Mahuang-Fuzi-Xixin decoction in the treatment of patients with mild bronchial asthma during acute exacerbation.
Gan W; Huang Q; Wang M; Wang J; Hui Y; Zhao K; Huang N; Liao T
Medicine (Baltimore); 2020 Aug; 99(35):e21858. PubMed ID: 32871910
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of TCM therapy of tonifying lung-kidney's Qi-deficiency in a case of idiopathic pulmonary fibrosis: A case report.
Chen MJ; Yang GL; Ding YX; Tong ZQ
Medicine (Baltimore); 2019 May; 98(18):e15140. PubMed ID: 31045757
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of traditional Chinese medicine in patients with acute exacerbation of idiopathic pulmonary fibrosis: study protocol for randomized, controlled, exploratory clinical trial.
Hailong Z; Jiansheng L; Wen G; Lu W; Dong Z; Limin Z; Miao Z; Weixian L
Trials; 2022 Feb; 23(1):103. PubMed ID: 35109889
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial for the effect of Modified Shenling Baizhu Powder on delaying the illness progress of COPD stable phase patients (GOLD 1-2 stages): A study protocol.
Liu Y; Xie X; Wang W; Zhao K; Xiao W; Xiao J; Chen J; Zeng J; Chen K
Medicine (Baltimore); 2020 Oct; 99(43):e22700. PubMed ID: 33120762
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial.
Behr J; Nathan SD; Wuyts WA; Mogulkoc Bishop N; Bouros DE; Antoniou K; Guiot J; Kramer MR; Kirchgaessler KU; Bengus M; Gilberg F; Perjesi A; Harari S; Wells AU
Lancet Respir Med; 2021 Jan; 9(1):85-95. PubMed ID: 32822614
[TBL] [Abstract][Full Text] [Related]
11. The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial.
Hammond M; Clark AB; Cahn AP; Chilvers ER; Fraser WD; Livermore DM; Maher TM; Parfrey H; Swart AM; Stirling S; Thickett D; Whyte M; Wilson A
Trials; 2018 Feb; 19(1):89. PubMed ID: 29402332
[TBL] [Abstract][Full Text] [Related]
12. Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis.
Richeldi L; Cottin V; Flaherty KR; Kolb M; Inoue Y; Raghu G; Taniguchi H; Hansell DM; Nicholson AG; Le Maulf F; Stowasser S; Collard HR
Respir Med; 2014 Jul; 108(7):1023-30. PubMed ID: 24834811
[TBL] [Abstract][Full Text] [Related]
13. Curative effect of Maimendong decoction in treating advanced lung cancer with Qi-Yin deficiency cough.
Zhang Y; Da C
Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):309-311. PubMed ID: 28625959
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
Behr J; Bendstrup E; Crestani B; Günther A; Olschewski H; Sköld CM; Wells A; Wuyts W; Koschel D; Kreuter M; Wallaert B; Lin CY; Beck J; Albera C
Lancet Respir Med; 2016 Jun; 4(6):445-53. PubMed ID: 27161257
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.
Ley B; Swigris J; Day BM; Stauffer JL; Raimundo K; Chou W; Collard HR
Am J Respir Crit Care Med; 2017 Sep; 196(6):756-761. PubMed ID: 28471697
[TBL] [Abstract][Full Text] [Related]
16. Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design.
Behr J; Nathan SD; Harari S; Wuyts W; Kirchgaessler KU; Bengus M; Gilberg F; Wells AU
Respir Med; 2018 May; 138():13-20. PubMed ID: 29724385
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin for the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis: A Randomized Controlled Crossover Trial.
Guler SA; Clarenbach C; Brutsche M; Hostettler K; Brill AK; Schertel A; Geiser TK; Funke-Chambour M
Ann Am Thorac Soc; 2021 Dec; 18(12):2018-2026. PubMed ID: 34015241
[No Abstract] [Full Text] [Related]
18. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of Jin-shui Huan-xian granule for idiopathic pulmonary fibrosis: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
Yang SG; Yu XQ; Li JS; Xie Y; Zhang W; Ban C; Feng J; Wu L; Lu X; Zhao L; Meng Y; Zhou M; He Y; Luo W
Trials; 2022 Sep; 23(1):725. PubMed ID: 36056382
[TBL] [Abstract][Full Text] [Related]
20. Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
Maher TM; Ford P; Brown KK; Costabel U; Cottin V; Danoff SK; Groenveld I; Helmer E; Jenkins RG; Milner J; Molenberghs G; Penninckx B; Randall MJ; Van Den Blink B; Fieuw A; Vandenrijn C; Rocak S; Seghers I; Shao L; Taneja A; Jentsch G; Watkins TR; Wuyts WA; Kreuter M; Verbruggen N; Prasad N; Wijsenbeek MS;
JAMA; 2023 May; 329(18):1567-1578. PubMed ID: 37159034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
